biotin and cyclosporine
biotin has been researched along with cyclosporine in 10 studies
Compound Research Comparison
| Studies (biotin) | Trials (biotin) | Recent Studies (post-2010) (biotin) | Studies (cyclosporine) | Trials (cyclosporine) | Recent Studies (post-2010) (cyclosporine) |
|---|---|---|---|---|---|
| 14,847 | 95 | 3,882 | 377 | 2 | 170 |
| 14,847 | 95 | 3,882 | 30,547 | 3,802 | 6,558 |
Protein Interaction Comparison
Research
Studies (10)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Antoni, F; Apati, A; Banfalvi, G; Lapis, K; Molnar, G; Schweighoffer, E; Schweighoffer, T | 1 |
| Andoh, TF; Bennett, WM; Couser, WG; Johnson, RJ; Pichler, RH; Shankland, SJ; Thomas, SE | 1 |
| Chalmers-Redman, RM; Rideout, HJ; Sugrue, MM; Tatton, WG; Wang, Y | 1 |
| Hatake, K; Ishizaka, Y; Osawa, Y; Shimura, M; Takaku, F; Yuo, A | 1 |
| Fischer, I; Murray, M; Shibata, M; Shumsky, JS; Tessler, A; Tobias, CA; Tuszynski, MH | 1 |
| Bucak, YY; Çelebi, S; Erdurmus, M; Kükner, A; Terzi, EH | 1 |
| Haarstad, AC; Heinrich, NA; McFadden, RA; Tomlinson, DJ | 1 |
Trials
1 trial(s) available for biotin and cyclosporine
| Article | Year |
|---|---|
A double-blinded, randomized, controlled, crossover evaluation of a zinc methionine supplement as an adjunctive treatment for canine atopic dermatitis.
Topics: Animals; Biotin; Cross-Over Studies; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Dietary Supplements; Dog Diseases; Dogs; Double-Blind Method; Drug Therapy, Combination; Fatty Acids, Essential; Female; Male; Methionine; Organometallic Compounds | 2017 |
Other Studies
9 other study(ies) available for biotin and cyclosporine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Cytometric analysis of DNA replication inhibited by emetine and cyclosporin A.
Topics: Animals; Biotin; Cyclosporine; Deoxyuracil Nucleotides; DNA Replication; Emetine; Flow Cytometry; Humans; Male; Mice; Mice, Inbred Strains; Microscopy, Fluorescence; T-Lymphocytes; Thymus Gland; Tumor Cells, Cultured | 1991 |
Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Apoptosis; Arginine; Biotin; Cyclosporine; Deoxyuracil Nucleotides; DNA Fragmentation; Enzyme Inhibitors; Fibrosis; Hydralazine; Immunosuppressive Agents; Ischemia; Kidney; Losartan; Macrophages; Male; Nephritis, Interstitial; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Staining and Labeling | 1998 |
Reduced mitochondrial membrane potential and altered responsiveness of a mitochondrial membrane megachannel in p53-induced senescence.
Topics: Animals; Apoptosis; Biotin; Cell Differentiation; Cell Membrane Permeability; Cellular Senescence; Cyclosporine; Fluorescent Dyes; Humans; Intracellular Membranes; Ion Channels; Membrane Potentials; Microscopy, Confocal; Mitochondria; Nerve Growth Factors; PC12 Cells; Permeability; Rats; Rhodamines; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1999 |
Oxidative stress as a necessary factor in room temperature-induced apoptosis of HL-60 cells.
Topics: Amino Acid Chloromethyl Ketones; Apoptosis; bcl-X Protein; Biotin; Caspase Inhibitors; Caspases; Cyclosporine; Cysteine Proteinase Inhibitors; Cytochrome c Group; Endopeptidases; Genes, bcl-2; HL-60 Cells; Humans; Intracellular Membranes; Mitochondria; Molecular Weight; Neoplasm Proteins; Oligopeptides; Oxidative Stress; Permeability; Protease Inhibitors; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Recombinant Fusion Proteins; Superoxide Dismutase; Superoxides; Temperature | 2000 |
Delayed grafting of BDNF and NT-3 producing fibroblasts into the injured spinal cord stimulates sprouting, partially rescues axotomized red nucleus neurons from loss and atrophy, and provides limited regeneration.
Topics: Animals; Atrophy; Axotomy; Biotin; Brain-Derived Neurotrophic Factor; Cell Count; Cell Size; Cell Survival; Cyclosporine; Dextrans; Female; Fibroblasts; GAP-43 Protein; Green Fluorescent Proteins; Immunohistochemistry; Immunosuppressive Agents; Luminescent Proteins; Nerve Regeneration; Neurons; Neurotrophin 3; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Red Nucleus; Spinal Cord Injuries | 2003 |
Inhibitory effects of topical cyclosporine A 0.05% on immune-mediated corneal neovascularization in rabbits.
Topics: Administration, Topical; Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal, Humanized; Apoptosis; Arthus Reaction; Bevacizumab; Biotin; Corneal Neovascularization; Cyclosporine; Deoxyuracil Nucleotides; Dexamethasone; Disease Models, Animal; Glucocorticoids; Immunoenzyme Techniques; Immunosuppressive Agents; In Situ Nick-End Labeling; Ophthalmic Solutions; Rabbits; Serum Albumin, Bovine | 2013 |